Results 291 to 300 of about 757,160 (318)
Some of the next articles are maybe not open access.
Prognostic factors in myelodysplastic syndromes
Leukemia Research, 1992The extreme variability in prognosis among patients with myelodysplastic syndromes (MDS) complicates decision-making regarding their therapy. Several studies carried out in recent years have recognized the prognostic value of some clinical and biological characteristics.
SANZ, GF, SANZ, MA
openaire +3 more sources
Prognostic factors in tympanoplasty.
The American journal of otology, 1998To assess the prognostic value of pathologic and technical variables influencing the functional outcome of tympanoplasty.Retrospective review of the records of 544 patients affected by chronic otitis with or without cholesteatoma, operated on by the senior author in a city hospital ENT department.
Albu S, Babighian G, Trabalzini F
openaire +2 more sources
[Prognostic factors in lymphomas].
La Revue du praticien, 2010Prognostic factors able to predict lymphoma patient's outcome are necessary to inform the patient and to choose the appropriate treatment. Beside the essential documentation of the pathological lymphoma subtype, several factors (such as age, performance status, Ann Arbor disease stage, LDH level...) easy to assess are used and help to establish ...
Bachy, E., Salles, Gilles
openaire +2 more sources
Prognostic Factors in Schizophrenia
Military Medicine, 1965A, KIEV, M B, GIFFEN
openaire +2 more sources
Prognostic Factors in Retinoblastoma
Journal of Pediatric Ophthalmology & Strabismus, 2000A D, Singh, C L, Shields, J A, Shields
openaire +2 more sources
Prognostic factors in medulloblastoma
The Lancet, 1992R J, Gilbertson +3 more
openaire +2 more sources
Evaluating prostate needle biopsy: therapeutic and prognostic importance
Ca-A Cancer Journal for Clinicians, 1997D G Bostwick
exaly
Implementing prognostic and predictive biomarkers in CRC clinical trials
Nature Reviews Clinical Oncology, 2011Wendy Moore +2 more
exaly
Prognostic factors in chronic lymphocytic leukemia—what do we need to know?
Nature Reviews Clinical Oncology, 2010, Paula Cramer, Cramer Paula
exaly

